CD63 and cancer: Though the authors in this study demonstrated that their assay was much more sensitive to the CD63‐positive EVs than the soluble CD63 protein, the interaction between the probe and the soluble proteins and/or protein aggregates in EV preparation or in the plasma might limit its utility in cancer diagnostics.